KR100517399B1 - 레슈마니아증의 치료에서 경구 투여를 위한 밀테포신을함유하는 고형 약제학적 조성물 - Google Patents

레슈마니아증의 치료에서 경구 투여를 위한 밀테포신을함유하는 고형 약제학적 조성물 Download PDF

Info

Publication number
KR100517399B1
KR100517399B1 KR10-2000-7008029A KR20007008029A KR100517399B1 KR 100517399 B1 KR100517399 B1 KR 100517399B1 KR 20007008029 A KR20007008029 A KR 20007008029A KR 100517399 B1 KR100517399 B1 KR 100517399B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
solid pharmaceutical
miltefosine
talc
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR10-2000-7008029A
Other languages
English (en)
Korean (ko)
Other versions
KR20010034311A (ko
Inventor
엥겔위르겐
사를리키오티스베르너
클렌너토마스
힐가르트페터
사우에르비어디터
밀슈만엑크하르트
Original Assignee
젠타리스 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 젠타리스 게엠베하 filed Critical 젠타리스 게엠베하
Publication of KR20010034311A publication Critical patent/KR20010034311A/ko
Application granted granted Critical
Publication of KR100517399B1 publication Critical patent/KR100517399B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR10-2000-7008029A 1998-01-22 1998-01-22 레슈마니아증의 치료에서 경구 투여를 위한 밀테포신을함유하는 고형 약제학적 조성물 Expired - Fee Related KR100517399B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1998/000345 WO1999037289A1 (en) 1998-01-22 1998-01-22 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis

Publications (2)

Publication Number Publication Date
KR20010034311A KR20010034311A (ko) 2001-04-25
KR100517399B1 true KR100517399B1 (ko) 2005-09-28

Family

ID=8166843

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-7008029A Expired - Fee Related KR100517399B1 (ko) 1998-01-22 1998-01-22 레슈마니아증의 치료에서 경구 투여를 위한 밀테포신을함유하는 고형 약제학적 조성물

Country Status (24)

Country Link
US (1) US6544551B1 (enExample)
EP (1) EP1051159B1 (enExample)
JP (1) JP2002501015A (enExample)
KR (1) KR100517399B1 (enExample)
CN (1) CN100413492C (enExample)
AT (1) ATE215817T1 (enExample)
AU (1) AU756805B2 (enExample)
BR (1) BR9814772A (enExample)
CA (1) CA2318260C (enExample)
CZ (1) CZ299229B6 (enExample)
DE (1) DE69804865T2 (enExample)
DK (1) DK1051159T3 (enExample)
ES (1) ES2175663T3 (enExample)
HU (1) HUP0004363A3 (enExample)
IL (1) IL136196A (enExample)
NO (1) NO20003674L (enExample)
NZ (1) NZ505648A (enExample)
PL (1) PL189654B1 (enExample)
PT (1) PT1051159E (enExample)
SI (1) SI1051159T1 (enExample)
SK (1) SK284839B6 (enExample)
TR (1) TR200001717T2 (enExample)
UA (1) UA68372C2 (enExample)
WO (1) WO1999037289A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7887817B2 (en) * 2002-01-25 2011-02-15 Aeterna Zentaris Gmbh Process for preventing protozoal diseases
DE10203195A1 (de) * 2002-01-25 2003-08-07 Zentaris Ag Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen
AU2002346284A1 (en) * 2002-04-26 2003-11-10 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
NZ538428A (en) 2002-07-30 2006-09-29 Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
ATE380027T1 (de) 2003-09-09 2007-12-15 Fumapharm Ag Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
ES2525497T3 (es) 2004-10-08 2015-10-09 Forward Pharma A/S Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
US8703179B2 (en) 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
WO2010020276A1 (en) * 2008-08-19 2010-02-25 Orphanidis Pharma Research Gmbh Treatment of coccidian parasites
CA2794513A1 (en) 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer
PT2642981T (pt) 2010-11-22 2017-06-16 Oblita Therapeutics Bvba Resumo
EP3616701A1 (en) 2011-06-24 2020-03-04 GRI Bio, Inc. Prevention and treatment of inflammatory conditions
JP2016515602A (ja) * 2013-04-08 2016-05-30 アカデミッシュ メディッシュ セントラム Ｉｂｄの治療に使用するためのミルテホシンまたはペリホシン
JP6566450B2 (ja) 2014-09-17 2019-08-28 ステアライフ・インディア・プライベート・リミテッド 発泡組成物及びそれを製造する方法
CN104473941A (zh) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 一种含有米替福新的药物制剂及其制备方法
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
PL3965739T3 (pl) 2019-04-12 2025-01-13 Oblita Therapeutics Bvba Postacie dawkowane będące tabletkami oleilofosfocholiny

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE888444C (de) * 1951-11-10 1953-08-31 Benckiser Gmbh Joh A Verfahren zum Tablettieren von hygroskopischen Praeparaten
IE59778B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicament with anti-tumour action containing hexadecylphosphocholine
US4762658A (en) * 1986-10-08 1988-08-09 Central Soya Company, Inc. Method of tableting of de-oiled phosphatides (lecithin)
EP0419998A3 (en) * 1989-09-27 1991-10-23 Asta Pharma Aktiengesellschaft Use of alkylphosphonic acid derivatives for the treatment of psoriasis
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis

Also Published As

Publication number Publication date
TR200001717T2 (tr) 2000-11-21
CA2318260C (en) 2006-11-21
HUP0004363A3 (en) 2002-12-28
AU6212198A (en) 1999-08-09
SI1051159T1 (en) 2002-10-31
DE69804865T2 (de) 2002-11-07
EP1051159B1 (en) 2002-04-10
CN1283111A (zh) 2001-02-07
NZ505648A (en) 2002-10-25
CZ20002596A3 (cs) 2000-10-11
SK9862000A3 (en) 2000-11-07
KR20010034311A (ko) 2001-04-25
PT1051159E (pt) 2002-09-30
CN100413492C (zh) 2008-08-27
DK1051159T3 (da) 2002-08-05
PL189654B1 (pl) 2005-09-30
ES2175663T3 (es) 2002-11-16
IL136196A (en) 2004-07-25
ATE215817T1 (de) 2002-04-15
NO20003674D0 (no) 2000-07-18
BR9814772A (pt) 2000-10-24
EP1051159A1 (en) 2000-11-15
CA2318260A1 (en) 1999-07-29
CZ299229B6 (cs) 2008-05-21
IL136196A0 (en) 2001-05-20
HUP0004363A2 (hu) 2001-04-28
NO20003674L (no) 2000-07-18
SK284839B6 (sk) 2005-12-01
DE69804865D1 (de) 2002-05-16
UA68372C2 (en) 2004-08-16
PL342838A1 (en) 2001-07-16
JP2002501015A (ja) 2002-01-15
WO1999037289A1 (en) 1999-07-29
US6544551B1 (en) 2003-04-08
AU756805B2 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
KR100517399B1 (ko) 레슈마니아증의 치료에서 경구 투여를 위한 밀테포신을함유하는 고형 약제학적 조성물
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
CN1197554C (zh) 固体类脂制剂
DE202004021680U1 (de) Feste pharmazeutische Zusammensetzung
EP0147741A2 (de) Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-Glycero-3-Phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
BG107038A (bg) Гелен паразитициден състав
US6251421B1 (en) Pharmaceutical composition containing psyllium fiber and a lipase inhibitor
DE602004007505T2 (de) Pioglitazonsulfat, pharmazeutische zusammensetzungen und deren anwendung
EP0205865B1 (de) Pharmazeutische Präparate mit antihypertensiver und kardioprotektiver Wirkung
KR102758107B1 (ko) 페오놀 및 아포시닌을 포함하는 액체 제형
RU2190390C2 (ru) Твердая фармацевтическая композиция для орального введения при лечении лейшманиоза и способ ее производства, фармацевтическая комбинация для лечения лейшманиоза у млекопитающих и способ лечения (варианты)
BG64968B1 (bg) Твърди фармацевтични състави, съдържащи милтефозин за орално приложение при лечението на leishmaniasis
KR100367877B1 (ko) 구연산칼륨을 주제로 한 요로결석 치료제중 분말 및 미립제형 의 제조방법
JPS58208231A (ja) コレカルシフエロ−ル誘導体含有薬剤
KR101688093B1 (ko) 가축용 이버멕틴 경구용 정제 복합 조성물 및 그 제조방법
MXPA00005298A (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
HK1033434A (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
HU181913B (en) Process for preparing synergetic pharmaceutical composition with skeleton muscle relaxing activity
DE3317280C2 (enExample)
JPH0643337B2 (ja) コリン・アセチル転移酵素活性賦活剤
IL44996A (en) Pharmaceuticals Containing History 5 - Mercaptopyridoxine for the Treatment of Rheumatoid Arthritis
NZ243613A (en) Tablet comprising praziquantel, pyrantel pamoate and oxantel pamoate in synergistic proportions for treatment of nematode infestations

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

FPAY Annual fee payment

Payment date: 20080828

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20090922

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090922